A Controlled Trial of the Effect of Folate Supplements on Homocysteine, Lipids and Hemorheology in End-Stage Renal Disease

Publisher： Karger

E-ISSN： 2235-3186|85|3|215-220

ISSN： 1660-8151

Source： Nephron, Vol.85, Iss.3, 2000-06, pp. : 215-220

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Methylenetetrahydrofolate Reductase Gene C677T Polymorphism, Plasma Homocysteine and Folate in End-Stage Renal Disease Dialysis and Non-Dialysis Patients

By  

Nephron, Vol. 92, Iss. 1, 2002-08 ,pp. : 235-239

Karger

Access to resources Recommend Favorite

Daily Hemofiltration for End-Stage Renal Disease: A Feasibility and Efficacy Trial

By  

Blood Purification, Vol. 22, Iss. 6, 2005-01 ,pp. : 481-489

Karger

Access to resources Recommend Favorite

Keloids and End-Stage Renal Disease

By  

Nephron, Vol. 80, Iss. 2, 1998-09 ,pp. : 244-246

Karger

Access to resources Recommend Favorite

Effect of Missed Hemodialysis Treatments on Mortality in Patients with End-Stage Renal Disease

By  

Nephron, Vol. 79, Iss. 3, 1998-06 ,pp. : 385-386

Karger

Access to resources Recommend Favorite

Propionyl-L-Carnitine Therapy: Effects on Endothelin-1 and Homocysteine Levels in Patients with Peripheral Arterial Disease and End-Stage Renal Disease

By  

Kidney and Blood Pressure Research, Vol. 29, Iss. 2, 2006-08 ,pp. : 100-107

Karger

Access to resources Recommend Favorite